ProfileGDS4718 / 242889_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 68% 65% 58% 60% 63% 57% 62% 56% 59% 60% 60% 64% 57% 56% 59% 58% 56% 59% 61% 77% 57% 59% 56% 59% 58% 55% 61% 62% 64% 62% 57% 58% 62% 60% 59% 58% 61% 57% 56% 55% 57% 61% 61% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.7419168
GSM549102patient 115, normal, homogenized [OPG study]6.4878765
GSM549104patient 119, normal, homogenized [OPG study]5.9777258
GSM549108patient 138, normal, homogenized [OPG study]6.1443460
GSM549119patient 077, normal, homogenized [OPG study]6.3654463
GSM549133patient 032, cancer, homogenized [OPG study]5.8763357
GSM549139patient 042, cancer, homogenized [OPG study]6.2787562
GSM549099patient 107, normal, homogenized [OPG study]5.8696956
GSM549109patient 139, normal, homogenized [OPG study]6.0636359
GSM549110patient 046, normal, homogenized [OPG study]6.1500660
GSM549114patient 063, normal, homogenized [OPG study]6.0679160
GSM549122patient 082, normal, homogenized [OPG study]6.4317664
GSM549134patient 033, cancer, homogenized [OPG study]5.9362157
GSM549136patient 036, cancer, homogenized [OPG study]5.8143256
GSM549140patient 044, cancer, homogenized [OPG study]6.0463659
GSM549111patient 047, normal, homogenized [OPG study]6.0114958
GSM549113patient 057, normal, homogenized [OPG study]5.8323956
GSM549132patient 031, cancer, homogenized [OPG study]6.0767259
GSM549137patient 038, cancer, homogenized [OPG study]6.1858661
GSM549142patient 047, cancer, homogenized [OPG study]7.3410577
GSM549100patient 110, normal, homogenized [OPG study]5.9205557
GSM549107patient 135, normal, homogenized [OPG study]6.0569159
GSM549115patient 068, normal, homogenized [OPG study]5.8272956
GSM549116patient 072, normal, homogenized [OPG study]6.0442359
GSM549120patient 078, normal, homogenized [OPG study]5.9820458
GSM549131patient 030, cancer, homogenized [OPG study]5.78655
GSM549118patient 074, normal, homogenized [OPG study]6.1842661
GSM549129patient 027, cancer, homogenized [OPG study]6.3254162
GSM549123patient 088, normal, homogenized [OPG study]6.4518764
GSM549124patient 006, cancer, homogenized [OPG study]6.2353562
GSM549126patient 015, cancer, homogenized [OPG study]5.8999657
GSM549128patient 025, cancer, homogenized [OPG study]6.0185558
GSM549103patient 117, normal, homogenized [OPG study]6.2595962
GSM549117patient 073, normal, homogenized [OPG study]6.0648560
GSM549138patient 041, cancer, homogenized [OPG study]6.060359
GSM549141patient 045, cancer, homogenized [OPG study]6.0033558
GSM549130patient 028, cancer, homogenized [OPG study]6.212861
GSM549101patient 111, normal, homogenized [OPG study]5.9516957
GSM549105patient 128, normal, homogenized [OPG study]5.870556
GSM549106patient 134, normal, homogenized [OPG study]5.7957855
GSM549112patient 048, normal, homogenized [OPG study]5.9140557
GSM549125patient 011, cancer, homogenized [OPG study]6.2049161
GSM549127patient 024, cancer, homogenized [OPG study]6.2209761
GSM549135patient 035, cancer, homogenized [OPG study]5.8933857